济生肾气汤联合α-2b干扰素治疗脾肾阳虚型HBeAg阳性慢性乙型肝炎疗效观察 |
| |
引用本文: | 周晓玲,谢胜,李灿,侯秋科.济生肾气汤联合α-2b干扰素治疗脾肾阳虚型HBeAg阳性慢性乙型肝炎疗效观察[J].河北中西医结合杂志,2013(34):3772-3773,3776. |
| |
作者姓名: | 周晓玲 谢胜 李灿 侯秋科 |
| |
作者单位: | 广西柳州市中医院,广西柳州545001 |
| |
摘 要: | 目的观察济生肾气汤联合α-2b干扰素治疗脾肾阳虚型HBeAg阳性慢性乙型肝炎(乙肝)的效果。方法68例脾肾阳虚型HBeAg阳性的慢性乙肝患者随机分为治疗组和对照组各34例,对照组单用重组人干扰素α-2b注射液500IU/mL皮下注射,隔日1次;治疗组采用干扰素α-2b注射联合济生肾气汤治疗。2组疗程均为48周。结果治疗组和对照组中医证候积分改善有效率分别为91%和76%,2组比较有显著性差异(P〈0.01);2组患者治疗后肝功能指标均得到明显改善(P均〈0.01);治疗组和对照组表面抗原阴转率分别为12%和9%,2组比较无显著性差异(P〉0,05);治疗组HBeAg阴转率62%、HBV—DNA阴转率74%,对照组HBeAg阴转率47%、HBV—DNA阴转率59%,2组比较有显著性差异(P均〈0.05);治疗组总有效率71%,对照组53%,治疗组显著优于对照组(P〈0.05)。结论重组人干扰素α-2b注射液联合济生肾气汤治疗脾肾阳虚型HBeAg阳性慢性乙肝疗效好。
|
关 键 词: | HBeAg阳性 慢性乙型肝炎 济生肾气汤 干扰素 |
Clinical efficacy of Jisheng Shenqi decoction combined with interferon in HBeAg - positive chronic hepatitis B of Spleen-kidney Yang deficiency |
| |
Authors: | Zhou Xiaoling Xie Sheng Li Can Hou Qiuke |
| |
Institution: | (Liuzhou Hospital of Traditional Chinese Medicine, Liuzhou 545001 , Guangxi, China) |
| |
Abstract: | Objective It is to observe the clinical efficacy of Jisheng Shenqi decoction combined with interferon -c~2b on chronic hepatitis B of Spleen-kidney Yang deficiency. Methods 68 patients with HBeAg positive chronic hepatitis B of Spleen- kidney Yang deficiency were randomly divided into treatment group and control group, 34 patients in each group. The patients in control group were treated with alpha- 2b interferon 500 IU/mL by subcutaneous injection, once every other day, and the patients in treatment group with alpha- 2b interferon combined with Jisheng Shenqi decoction (2 times/day) , both the treat- ment courses were 12 months. Results The improving effective rates of syndrome scores in treatment group and control group were 91% and 76% respectively, compared with each other, the difference was significant (P 〈 0.01 ). The indexes of liver function in both groups were obviously improved after treatment ( P 〈 0.01 ). HBsAg negative conversion ratio was 12% in treatment group and 9% in control group(P 〉 0.05 ) , there was no significant difference between both groups. The negative conversion ratios of HBeAg and HBV -DNA were 62% and 74% respectively in treatment group, and those in control group were 47% and 59% in control group( P 〈 0.05 ). The total effective rates of treatment group was 71% , which was significant- ly higher than that of 53% in control group after treatment. Conclusion Jisheng Shenqi decoction combined with alpha -2b in- terferon has a good curative effect on HBeAg positive chronic hepatitis B of Spleen-kidney Yang deficiency. |
| |
Keywords: | HBeAg positive chronic hepatitis B Jisheng Shenqi decoction interferon |
本文献已被 维普 等数据库收录! |
|